Karyopharm Therapeutics Stock Forecast - 8 Period Moving Average

KPTI Stock  USD 1.39  0.09  6.08%   
The 8 Period Moving Average forecasted value of Karyopharm Therapeutics on the next trading day is expected to be 1.40 with a mean absolute deviation of  0.11  and the sum of the absolute errors of 6.06. Karyopharm Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Karyopharm Therapeutics stock prices and determine the direction of Karyopharm Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Karyopharm Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Karyopharm Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Karyopharm Therapeutics' systematic risk associated with finding meaningful patterns of Karyopharm Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Karyopharm Therapeutics to cross-verify your projections.
For more detail on how to invest in Karyopharm Stock please use our How to Invest in Karyopharm Therapeutics guide.
  
As of now, Karyopharm Therapeutics' Asset Turnover is increasing as compared to previous years. . The Karyopharm Therapeutics' current Common Stock Shares Outstanding is estimated to increase to about 119.9 M, while Net Loss is projected to decrease to (156.2 M).

Open Interest Against 2024-04-19 Karyopharm Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Karyopharm Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Karyopharm Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Karyopharm Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Karyopharm Therapeutics' open interest, investors have to compare it to Karyopharm Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Karyopharm Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Karyopharm. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Karyopharm Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Karyopharm Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Karyopharm Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
An 8-period moving average forecast model for Karyopharm Therapeutics is based on an artificially constructed time series of Karyopharm Therapeutics daily prices in which the value for a trading day is replaced by the mean of that value and the values for 8 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

Karyopharm Therapeutics 8 Period Moving Average Price Forecast For the 29th of March

Given 90 days horizon, the 8 Period Moving Average forecasted value of Karyopharm Therapeutics on the next trading day is expected to be 1.40 with a mean absolute deviation of 0.11, mean absolute percentage error of 0.03, and the sum of the absolute errors of 6.06.
Please note that although there have been many attempts to predict Karyopharm Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Karyopharm Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Karyopharm Therapeutics Stock Forecast Pattern

Backtest Karyopharm TherapeuticsKaryopharm Therapeutics Price PredictionBuy or Sell Advice 

Karyopharm Therapeutics Forecasted Value

In the context of forecasting Karyopharm Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Karyopharm Therapeutics' downside and upside margins for the forecasting period are 0.01 and 9.79, respectively. We have considered Karyopharm Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.39
1.40
Expected Value
9.79
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 8 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Karyopharm Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Karyopharm Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria99.8946
BiasArithmetic mean of the errors -0.0496
MADMean absolute deviation0.1143
MAPEMean absolute percentage error0.0919
SAESum of the absolute errors6.0563
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. Karyopharm Therapeutics 8-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for Karyopharm Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Karyopharm Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Karyopharm Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.071.399.78
Details
Intrinsic
Valuation
LowRealHigh
0.051.089.47
Details
7 Analysts
Consensus
LowTargetHigh
6.076.677.40
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Karyopharm Therapeutics. Your research has to be compared to or analyzed against Karyopharm Therapeutics' peers to derive any actionable benefits. When done correctly, Karyopharm Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Karyopharm Therapeutics.

Other Forecasting Options for Karyopharm Therapeutics

For every potential investor in Karyopharm, whether a beginner or expert, Karyopharm Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Karyopharm Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Karyopharm. Basic forecasting techniques help filter out the noise by identifying Karyopharm Therapeutics' price trends.

Karyopharm Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Karyopharm Therapeutics stock to make a market-neutral strategy. Peer analysis of Karyopharm Therapeutics could also be used in its relative valuation, which is a method of valuing Karyopharm Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Karyopharm Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Karyopharm Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Karyopharm Therapeutics' current price.

Karyopharm Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Karyopharm Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Karyopharm Therapeutics shares will generate the highest return on investment. By undertsting and applying Karyopharm Therapeutics stock market strength indicators, traders can identify Karyopharm Therapeutics entry and exit signals to maximize returns.

Karyopharm Therapeutics Risk Indicators

The analysis of Karyopharm Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Karyopharm Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting karyopharm stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Karyopharm Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Karyopharm Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Karyopharm Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Karyopharm Therapeutics Stock:
Check out Historical Fundamental Analysis of Karyopharm Therapeutics to cross-verify your projections.
For more detail on how to invest in Karyopharm Stock please use our How to Invest in Karyopharm Therapeutics guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Karyopharm Stock analysis

When running Karyopharm Therapeutics' price analysis, check to measure Karyopharm Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Karyopharm Therapeutics is operating at the current time. Most of Karyopharm Therapeutics' value examination focuses on studying past and present price action to predict the probability of Karyopharm Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Karyopharm Therapeutics' price. Additionally, you may evaluate how the addition of Karyopharm Therapeutics to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Is Karyopharm Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Karyopharm Therapeutics. If investors know Karyopharm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Karyopharm Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.25)
Revenue Per Share
1.279
Quarterly Revenue Growth
0.005
Return On Assets
(0.27)
Return On Equity
(8.91)
The market value of Karyopharm Therapeutics is measured differently than its book value, which is the value of Karyopharm that is recorded on the company's balance sheet. Investors also form their own opinion of Karyopharm Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Karyopharm Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Karyopharm Therapeutics' market value can be influenced by many factors that don't directly affect Karyopharm Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Karyopharm Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Karyopharm Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Karyopharm Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.